Clinical Trial Update: Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of liposomal irinotecan with temozolomide and bevacizumab in advanced soft tissue sarcoma (excluding GIST), not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Liposomal irinotecan (liposomal irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Soft Tissue Sarcoma (Excluding GIST) | Phase 2 | Status: NOT_YET_RECRUITING